1.Alternative Name:IL23R
2.Target:IL-23R
3.Source:Human IL-23R was expressed from HEK293 with human IgG1 FC at the C-terminal
4.Sequence:Gly24-Gly355
5.Protein structure::Q5VWK5hFC
6.Molecular Characterization:The protein has a calculated MW of 64kDa.The reducing (R) heterodimer protein migrates as 80-110 kDa due to glycosylation
7.Purity:SDS-PAGE>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 95%.

12.SEC-HPLC

When Recombinant Human IL-23R/hFC Protein is immobilized at 2μg/mL (100 μL/well), the concentration of Anti Human IL-23R Antibody(clone TC48-8B10.D5) that produces 50% of the optimal binding response is approximately 40 ng/ml.

13.ELISA

Recombinant Human IL-23R/hFC Protein（Cat.No.B21815809）captured on Protein A chip , can bind Recombinant Human IL-23 alpha&IL-12 beta /His Protein（Cat.No.B21815810）with a KD constant of 1.74E-08 M, determined in a SPR assay .

14.Note：For research use only .